[Treatment of cardiac arrhythmias with practolol, a new heart specific beta receptor blocking agent].
D000083:Acetanilides / Q000009:adverse effects; D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001249:Asthma / Q000188:drug therapy; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D012119:Respiration / Q000187:drug effects; D013565:Sympatholytics / Q000009:adverse effects / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics
Die Behandlung von Herzrhythmusstörungen mit Practolol, einem neuen herzspezifischen  Beta-Rezeptoren-Blocker.